Bionor Pharma

Bionor Pharma is a biotechnology company that focuses on pioneering soy technology for better health and wellness. Since its establishment in 1993, the company has been dedicated to developing soy-based technologies for the prevention and treatment of lifestyle-related diseases. Their product line includes Nutrilett and NutriPro, specially designed for weight management, as well as Abacor, a patented blend targeting cholesterol reduction. Additionally, Nutri5 addresses menopausal and pre-menstrual symptoms, and the company also offers nutrition products such as NutriBar and Nutri Femme. Operating in Nordic countries, Russia, and the Commonwealth of Independent States, Bionor Pharma ASA, originally named Nutri Pharma ASA, underwent a rebranding on June 14, 2010. The company is headquartered in Oslo, Norway. Although specific investment details are not available, Bionor Pharma ASA presents an intriguing opportunity for investors in the biotechnology and healthcare industries.